ProShare Advisors
DNTH icon

ProShare Advisors’s Dianthus Therapeutics DNTH Stock Holding History

ProShare Advisors’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$523K Sell
5,941
-253
-4% -$26.3K ﹤0.01% 1009
2026
Q2 		$604K Buy
6,194
+997
+19% +$87.1K ﹤0.01% 982
2026
Q1 		$436K Buy
+5,197
New +$301K ﹤0.01% 1146
2022
Q2 		– Sell
-731
Closed -$34K – 1881
2022
Q1 		$34K Sell
731
-195
-21% -$10.7K ﹤0.01% 2143
2021
Q4 		$67K Sell
926
-96
-9% -$9.6K ﹤0.01% 2248
2021
Q3 		$119K Sell
1,022
-117
-10% -$13.6K ﹤0.01% 1891
2021
Q2 		$178K Buy
1,139
+376
+49% +$69.1K ﹤0.01% 2176
2021
Q1 		$145K Buy
763
+10
+1% +$1.68K ﹤0.01% 2114
2020
Q4 		$94K Buy
753
+109
+17% +$12.4K ﹤0.01% 1997
2020
Q3 		$70K Buy
+644
New +$76.3K ﹤0.01% 1563
2020
Q1 		– Sell
-690
Closed -$167K – 1280
2019
Q4 		$167K Sell
690
-103
-13% -$19.2K ﹤0.01% 1630
2019
Q3 		$130K Sell
793
-5
-0.6% -$950 ﹤0.01% 1514
2019
Q2 		$188K Sell
798
-4
-0.5% -$989 ﹤0.01% 1452
2019
Q1 		$211K Buy
802
+74
+10% +$12.8K ﹤0.01% 1444
2018
Q4 		$66K Buy
+728
New +$99.2K ﹤0.01% 1513

Other funds holding DNTH

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return
Profund Advisors
Profund Advisors Bethesda, Maryland $3.48B AUM 66.96% 1-Year Est. Return
Peak Financial Advisors
Peak Financial Advisors Denver, Colorado $232M AUM 12.16% 1-Year Est. Return
Virginia Retirement Systems
Virginia Retirement Systems Richmond, Virginia $16.3B AUM 35.33% 1-Year Est. Return
STRS Ohio
STRS Ohio Columbus, Ohio $27.1B AUM 34.64% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $84.4B AUM 20.16% 1-Year Est. Return
QP Wealth Management
QP Wealth Management Eatontown, New Jersey $66.5M AUM 63.94% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $146M AUM 39.94% 1-Year Est. Return

ProShare Advisors's DNTH Position: Q3 2026 in Review

ProShare Advisors reduced its Dianthus Therapeutics (DNTH) stake by 4.1% in Q3 2026, selling an estimated $26.3K and leaving 5,941 shares worth $523K. The position accounts for ﹤0.01% of the portfolio, ranked #1009.

ProShare Advisors first reported a position in DNTH in Q4 2018 and has held it in 15 quarters since. The position peaked at $604K in Q2 2026. 39 funds tracked by Wall St. Rank hold DNTH as of Q3 2026.

  • ProShare Advisors held 5,941 shares of Dianthus Therapeutics worth $523K as of Q3 2026.
  • ProShare Advisors sold 253 Dianthus Therapeutics shares in Q3 2026, an estimated $26.3K.
  • Dianthus Therapeutics made up ﹤0.01% of ProShare Advisors's portfolio in Q3 2026, its #1009 holding.
  • ProShare Advisors first reported a position in Dianthus Therapeutics in Q4 2018 and has held it in 15 quarters since.
  • ProShare Advisors's Dianthus Therapeutics position peaked at $604K in Q2 2026.
  • 39 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q3 2026.

Based on ProShare Advisors's 13F filing for Q3 2026, filed 29 Oct 2026.